标题
Development of cytarabine prodrugs and delivery systems for leukemia treatment
作者
关键词
-
出版物
Expert Opinion on Drug Delivery
Volume 7, Issue 12, Pages 1399-1414
出版商
Informa Healthcare
发表日期
2010-10-22
DOI
10.1517/17425247.2010.527330
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism
- (2010) Youcef Mehellou et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cationic lipid-mediated nucleic acid delivery: beyond being cationic
- (2010) N. Madhusudhana Rao CHEMISTRY AND PHYSICS OF LIPIDS
- Current and emerging therapies for acute myeloid leukemia
- (2010) Tadeusz Robak et al. CLINICAL THERAPEUTICS
- Induction therapy in acute myeloid leukemia: intensifying and targeting the approach
- (2010) Hugo F Fernandez et al. CURRENT OPINION IN HEMATOLOGY
- Strategy for effective brain drug delivery
- (2010) M. Intakhab Alam et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Liposomal cancer therapy: exploiting tumor characteristics
- (2010) Thomas Kaasgaard et al. Expert Opinion on Drug Delivery
- Emerging drugs for chronic myeloid leukemia
- (2010) Daniela Cilloni et al. EXPERT OPINION ON EMERGING DRUGS
- Emerging therapy for the treatment of acute lymphoblastic leukemia
- (2010) Amber Fullmer et al. EXPERT OPINION ON EMERGING DRUGS
- Pharmacogenomics of pediatric acute lymphoblastic leukemia
- (2010) Nathan D Meeker et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clinical applications of PET and PET/CT in pediatric malignancies
- (2010) Rakesh Kumar et al. Expert Review of Anticancer Therapy
- Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts
- (2010) Wah-Seng Lim et al. LEUKEMIA RESEARCH
- The molecular pathology of cancer
- (2010) Timothy J. R. Harris et al. Nature Reviews Clinical Oncology
- Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
- (2010) Amr S. Abu Lila et al. PHARMACEUTICAL RESEARCH
- Current issues in research on structure–property relationships in polymer nanocomposites
- (2010) J. Jancar et al. POLYMER
- Novel Drug Delivery Systems for Sustained and Targeted Delivery of Anti-Cancer Drugs: Current Status and Future Prospects
- (2010) Puneet Utreja et al. Current Drug Delivery
- Special feature of mixed phosphotriester derivatives of cytarabine
- (2009) Marie-Hélène Gouy et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Advances in gene delivery through molecular design of cationic lipids
- (2009) Santanu Bhattacharya et al. CHEMICAL COMMUNICATIONS
- Biodegradable polymeric nanoparticles based drug delivery systems
- (2009) Avnesh Kumari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-β-arabinofuranosylcytosine
- (2009) Boyang Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues
- (2009) Larryn W Peterson et al. Expert Opinion on Drug Delivery
- Ligand-based targeted therapy for cancer tissue
- (2009) Manasi Das et al. Expert Opinion on Drug Delivery
- Emerging trends of nanomedicine - an overview
- (2009) Selvarajan Sandhiya et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Niosomes in sustained and targeted drug delivery: some recent advances
- (2009) Adnan Azeem et al. JOURNAL OF DRUG TARGETING
- A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma – long-term results of a multicenter observation study
- (2009) Oliver Weigert et al. LEUKEMIA & LYMPHOMA
- Intravenous administration of CP-4055 (ELACYT™) in patients with solid tumours. A phase I study
- (2008) Svein Dueland et al. ACTA ONCOLOGICA
- CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines
- (2008) Carlos M. Galmarini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma
- (2008) Hüseyin Abalı et al. CANCER INVESTIGATION
- Chitosan-Based Thermosensitive Hydrogel Containing Liposomes for Sustained Delivery of Cytarabine
- (2008) Rohit Mulik et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments
- (2008) Martin Benesch et al. EXPERT OPINION ON PHARMACOTHERAPY
- Recent advances in management of acute myeloid leukemia (AML)
- (2008) Manasi Shah et al. INDIAN JOURNAL OF PEDIATRICS
- Pharmacokinetics of CPX-351 (Cytarabine/Daunorubicin HCl) Liposome injection in the mouse
- (2008) William F. Bayne et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Anti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
- (2008) David J. Adams et al. LEUKEMIA & LYMPHOMA
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
- Synthesis, Transport and Pharmacokinetics of 5′-Amino Acid Ester Prodrugs of 1-β-d-Arabinofuranosylcytosine
- (2008) Yongbing Sun et al. MOLECULAR PHARMACEUTICS
- Modern approaches to treating chronic myelogenous leukemia
- (2008) Javier Pinilla-Ibarz et al. Current Oncology Reports
- Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting
- (2007) Fujun Li et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started